China Short-read Sequencing Market Size & Outlook
Related Markets
China short-read sequencing market highlights
- The China short-read sequencing market generated a revenue of USD 306.6 million in 2023 and is expected to reach USD 1,490.1 million by 2030.
- The China market is expected to grow at a CAGR of 25.3% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
Short-read sequencing market data book summary
| Market revenue in 2023 | USD 306.6 million |
| Market revenue in 2030 | USD 1,490.1 million |
| Growth rate | 25.3% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Services |
| Key market players worldwide | Illumina Inc, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Birks Group Inc Class A, Qiagen NV, Agilent Technologies Inc, Macrogenics Inc, Azenta Inc, PerkinElmer, ProPhase Labs Inc |
Other key industry trends
- In terms of revenue, China accounted for 5.4% of the global short-read sequencing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China short-read sequencing market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,490.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Short-read Sequencing Market Scope
Short-read Sequencing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| ProPhase Labs Inc | View profile | 113 | 711 Stewart Avenue, Suite 200, Garden City, NY, United States, 11530 | https://www.prophaselabs.com |
| Birks Group Inc Class A | View profile | 313 | 2020 Robert-Bourassa Boulevard, Suite 200, Montreal, QC, Canada, H3A 2A5 | https://www.birks.com |
| Pacific Biosciences of California Inc | View profile | 796 | 1305 O’Brien Drive, Menlo Park, CA, United States, 94025 | https://www.pacb.com |
| Macrogenics Inc | View profile | 339 | 9704 Medical Center Drive, Rockville, MD, United States, 20850 | https://www.macrogenics.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.perkinelmer.com |
| Azenta Inc | View profile | 3400 | 200 Summit Drive, 6th Floor, Burlington, MA, United States, 01803 | https://www.azenta.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
China short-read sequencing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to short-read sequencing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 61.81% in 2023. Horizon Databook has segmented the China short-read sequencing market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
China is expected to play a leading role in advancement of cutting-edge precision medicine globally. For this, the country is focused on advancements in the field of precision medicine, population genomics, clinical diagnostics, and personal wellness. The move is already reported to be attracting private investments.
Chinese players such as Beijing Genomics Institute (BGI), WuXi PharmaTech, Novogene, and Cloud Health have purchased state-of-the-art sequencing technology from Illumina to support China’s precision-medicine initiative. Moreover, local players have also collaborated with hospitals to enhance the use of precision medicine in the country.
Moreover, local presence of prominent sequencing players such as BGI accounts for a significant share of China in the Asia-Pacific short read sequencing market. BGI has also integrated NGS platforms and applications such as pre-natal screening, oncology, idiopathic and infectious disease investigation and research in China, and has installed over 120 HiSeq 2000 genome sequencers by Illumina.
Reasons to subscribe to China short-read sequencing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China short-read sequencing market databook
-
Our clientele includes a mix of short-read sequencing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China short-read sequencing market , including forecasts for subscribers. This country databook contains high-level insights into China short-read sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China short-read sequencing market size, by product, 2018-2030 (US$M)
China Short-read Sequencing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
